Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q2 2025 · 10-Q
Revenue$4.75M$4.75M+8.5% vs Q2 2024 Net Income-$480.76K-$480.76KN/M vs Q2 2024 EPS, diluted—
Gross Profit$2,959,364+14.7% Operating Income-$485,816N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$189,477N/M Free Cash Flowderived-$204,983N/M Margins · derivedGross margin62.3%+3.3 pt vs Q2 2024
Operating margin-10.2%+25.2 pt vs Q2 2024
Net margin-10.1%+58.7 pt vs Q2 2024
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end